Statin-associated muscle symptoms: Myth or reality?

Area of Science:

• Pharmacology
• Clinical Medicine
• Toxicology

Background:

• Statin-associated muscle symptoms (SAMS) are a spectrum of clinical issues linked to statin use.
• Despite widespread statin prescription, the exact incidence, mechanisms, diagnosis, and optimal management of SAMS are still debated.
• Increased statin use has led to more reported adverse muscular reactions, highlighting the complexity of this drug-adverse effect relationship.

Purpose of the Study:

• To review and integrate current evidence on statin-associated muscle symptoms.
• To clarify the complex relationship between statin therapy and muscular adverse effects.
• To aid clinicians and patients in understanding and managing SAMS.

Main Methods:

• Systematic review of published literature on statin-associated muscle symptoms.
• Analysis of studies investigating incidence, pathophysiology, diagnosis, and treatment of SAMS.
• Integration of diverse evidence to address controversies.

Main Results:

• The incidence, pathophysiology, diagnosis, and treatment of SAMS remain subjects of ongoing scientific discussion.
• Methodological variations across studies contribute to the complexity and controversy surrounding SAMS.
• A significant increase in reported muscular adverse events associated with statins has been observed.

Conclusions:

• A comprehensive understanding of SAMS is hindered by conflicting study results and methodologies.
• Integrating existing evidence is crucial for improving the clinical management of statin-associated muscle symptoms.
• Further research and standardized approaches are needed to resolve controversies surrounding SAMS.